Navigation Links
Carl Hull Named President and Chief Operating Officer of Gen-Probe
Date:2/11/2008

SAN DIEGO, Feb. 11 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that Carl W. Hull has been named the Company's president and chief operating officer, effective March 1, 2008.

Mr. Hull, 50, joined Gen-Probe in February of 2007 as executive vice president and chief operating officer. He oversees the Company's major operating functions, including research and development, manufacturing, and sales and marketing.

"Carl's extensive industry experience and knowledge have been an asset to Gen-Probe over the last year," said Henry L. Nordhoff, Gen-Probe's chairman and chief executive officer. "His promotion reflects his contributions to date and the board's confidence in his future leadership."

Mr. Hull, a 26-year veteran of the diagnostics and life sciences industries, joined Gen-Probe from Applied Biosystems, where he was vice president and general manager of the Sequence Detection System and Microarrays business unit, which sells genomic testing systems and reagents. Before joining Applied Biosystems in 2005, Mr. Hull was chief executive officer of Applied Imaging Corporation. Prior to joining Applied Imaging in 1997, he held a variety of marketing and sales management positions at Ventana Medical Systems and Abbott Laboratories, both in the United States and internationally.

Mr. Hull earned a BA in political science and international relations from The Johns Hopkins University and an MBA from the University of Chicago.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning plans and objectives of management are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. Some of these risks, uncertainties and assumptions include, but are not limited to, the risk that management may not be successful in implementing its business plans, and the risk that the Company may not be able to retain its top executives or attract new ones. The foregoing sets forth some, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we file with the SEC, including our most recent annual report on Form 10-K and all subsequent periodic reports. We assume no obligation and expressly disclaim any duty to update forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

Contact:

Michael Watts

Senior director, investor relations and

corporate communications

858-410-8673


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
2. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
3. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
4. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
5. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
6. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
7. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
8. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
9. Ikaria Founding Scientist Named 2007 MacArthur Fellow
10. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
11. Abbott Named One of the Best Places to Launch a Career by BusinessWeek
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/10/2017)... ... October 10, 2017 , ... The ... prestigious awards honoring scientists who have made outstanding contributions to analytical ... during Pittcon 2018, the world’s leading conference and exposition for laboratory science, which ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
Breaking Biology News(10 mins):